Eli Lilly (LLY) stock has continued its gradual ascent this month, building on a year marked by steady performance. Investors ...

TLDR Novo Nordisk launched an unsolicited $9 billion offer for Metsera, trumping Pfizer’s existing $7.3 billion acquisition ...

Merck announced that sales of Keytruda topped more than $8 billion for the first time in a quarter, up 10% from the same period a year ago. The pharma giant also narrowed its full-year profit outlook ...

A bitter takeover battle has erupted in the fat jab market after Danish drug giant Novo Nordisk gatecrashed a takeover deal ...

11 March 2025 The multinational claims Mylan Pharmaceuticals’ generic of its blockbuster weight loss drug infringes another ...

Novo Nordisk has made an unsolicited, approximately up to $9 billion bid for Metsera—more than a month after Pfizer announced its intent to buy the company for up to $7.3 billion.

Preview this article 1 min The restaurant was a mainstay in downtown Bethesda for more than three decades. Another pharma ...

For decades Johnson and Johnson covered up the fact that their talcum powder was contaminated with asbestos and was allegedly ...

Merck shares dipped after strong earnings and higher profit guidance, as the company narrowed its 2025 sales forecast amid ...

Merck, which has claimed bragging rights as the maker of the world’s best-selling drug, Keytruda, since 2023, has officially ...

Speedskater Erin Jackson spoke about living with eczema. By registering you consent to the collection and use of your information to provide the products and services you have requested from us and as ...

Novo Nordisk launched a bid valued at up to $9 billion for obesity-drug developer Metsera, hoping to trump an already agreed-on deal Pfizer made for the U.S. company last month.